Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C

Technology appraisal guidance
Reference number: TA106
Published: 23 August 2006
Last updated: 27 November 2013

TA106 Hepatitis C - peginterferon alfa and ribavirin: Appendix B - GE Proposal Paper September 2013

TA106 Hepatitis C - peginterferon alfa and ribavirin: Appendix B - GE Proposal Paper September 2013

TA106 Hepatitis C - peginterferon alfa and ribavirin: Appendix B - GE Proposal Paper September 2013
14 October 2013
(534.1 Kb 35 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 09 October 2013